Primrose Therapeutics is engaged in the development of treatments for polycystic kidney disease. PKD is one of the most common life-threatening genetic disorders which results in the abnormal growth of cells in the kidney, that eventually lead to the development of bilateral kidney cysts and structural destruction of the kidney.